ABC | Volume 114, Nº2, February 2020

Update Update of the Brazilian Guideline on Nuclear Cardiology – 2020 Arq Bras Cardiol. 2020; 114(2):325-429 1. AzambujaMIR, FoppaM, MaranhãoMF, Achutti AC. Impacto econômico dos casos de doença cardiovascular grave no Brasil: uma estimativa baseada em dados secundários. Arq Bras Cardiol. 2008;91(3):163-71. 2. Teich V, Araujo DV. Estimativa de custo da síndrome coronariana aguda no Brasil. Rev Bras Cardiol. 2011;24(2):85-94. 3. Des Prez RD, Shaw LJ, Gillespie RL, Jaber WA, Noble GL, Soman P, et al. Cost-effectiveness of myocardial perfusion imaging: A summary of the currently available literature. J Nucl Cardiol. 2005;12(6):750-9. 4. ShawLJ, Hachamovitch R, BermanDS, Marwick TH, LauerMS, Heller GV, et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: An observational assessment of the value of precatheterization ischemia. J AmColl Cardiol. 1999;33(3):661-9. 5. Volschan A. Challenges for Contemporary Medicine: Implementation of Evidence in Clinical Practice. Int J Cardiovasc Sci. 2016;29(4):250-2. 6. Underwood SR, Godman B, Salyani S, Ogle JR, Ell PJ. Economics of myocardial perfusion imaging in Europe-the EMPIRE Study. Eur Heart J. 1999;20(2):157-66. 7. Cerci JJ, Trindade E, Preto D, Cerci RJ, Lemos PA, Cesar LA, et al. Investigation route of the coronary patient in the public health system in Curitiba, Sao Paulo and in Incor - IMPACT study. Arq Bras Cardiol. 2014;103(3):192-200. 8. Foy AJ, Dhruva SS, Peterson B, Mandrola JM, Morgan DJ, Redberg RF. Coronary computed tomography angiography vs functional stress testing for patients with suspected coronary artery disease: A systematic review and meta-analysis. JAMA Intern Med. 2017;177(11):1623-31. 9. Stillman AE, Gatsonis C, Lima JA, Black WC, Cormack J, Gareen I, et al. Rationale and design of the Randomized Evaluation of patients with Stable angina ComparingUtilization of noninvasive Examinations (RESCUE) trial. AmHeart J. Sep 2016; 179:19-28. 10. KimAS, Johnston SC. Global variation in the relative burden of stroke and ischemic heart disease. Circulation. 2011;124(3):314-23. 11. Hendel RC, Berman DS, Di Carli MF, Heidenreich PA, Henkin RE, Pellikka PA, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. J Am Coll Cardiol. 2009;53(23):2201-29. 12. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126(25):e354-471. 13. Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher B, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart AssociationTaskForceonPracticeGuidelines,andtheAmericanAssociation forThoracicSurgery,PreventiveCardiovascularNursesAssociation,Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J AmColl Cardiol. 2014;64(18):1929-49. 14. Cesar LA, Ferreira JF, Armaganijan D, Gowdak LH, Mansur AP, Bodanese LC, et al. Diretriz de doença coronária estável. Arq Bras Cardiol. 2014;103(2 Suppl 2):1-59. 15. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541-619. 16. Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, Hert SD,et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessmentandmanagement:The JointTaskForceonnon-cardiacsurgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35(35):2383-431. 17. Mastrocola LE, Lopes RW, Boccia D, Alves FB. Cardiologia Nuclear: princípios. In: Moreira MC, Montenegro ST, Paola AAV de. Livro Texto da Sociedade Brasileira de Cardiologia. Seção 8: Imagem não Invasiva: Ressonância Magnética, Tomografia Computadorizada e Medicina Nuclear. 2ª ed. São Paulo: Manole; 2015.Cap 1, Seção 8. p. 441- 452. 18. Meneghetti JC, Falcão AM, Buchpiguel CA, Mastrocola LE. Cardiologia Nuclearepequisadeviabilidademiocárdica.In:MoreiraMC,Montenegro ST, Paola AA (eds). Livro Texto da SBC. 2ª ed. São Paulo:Manole; 2015. p. 629-34. 19. Schinkel AF, Bax JJ, Delgado V, Poldermans D, Rahimtoola SH. Clinical relevance of hibernating myocardium in ischemic left ventricular dysfunction. Am J Med. 2010;123(11):978-86. 20. Rahimtoola SH, Dilsizian V, Kramer CM, Marwick TH, Vanoverschelde JL. Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice. JACCCardiovasc Imaging. 2008;1(4):536-55. 21. Soman P, Udelson JE, Bax JJ, Downey BC. Assessment of myocardial viability by nuclear imaging in coronary heart disease. Up to Date. 2017. [cited in 2018 June 10]: Available from: https://www.uptodate.com/ contents/assessment-of-myocardial-viability-by-nuclear-imaging-in- coronary-heart-disease. 22. Dilsizian V: SPECT and PET myocardial perfusion imaging: Tracers and techniques. In Dilsizian V, Narula J, Braunwald E, (eds): Atlas of Nuclear Cardiology. 4th ed. New York: Springer. 2013. p. 55-94. 23. Udelson, JE, Dilsizian, V, Bonow RO. Nuclear Cardiology: Technical aspects of image acquisition display and interpretation. In: Mann DL, Zipes DP, Libby P, Bonow RO, Braunwald, E. epds. Braunwald’s Heart Disease. A Textbook of Cardiovascular Medicine. 10th ed. Philadelphia: Elsevier;2015. p.271-287. 24. INTERNATIONAL ATOMIC ENERGY AGENCY, Nuclear Cardiology: Guidance on the Implementation of SPECTMyocardial Perfusion Imaging, IAEA Human Health Series 23 (Rev. 1);2016. 25. Medical Advisory Secretariat. Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence- based analysis. Ont Health Technol Assess Ser. 2010; 10(8):1-64. 26. Nielsen AP, Morris KG, Murdock R, Bruno FP, Cobb FR. Linear relationship between the distribution of thallium-201 and blood flow in ischemic and nonischemic myocardium during exercise. Circulation. 1980;61(4):797-801. 27. Krivokapich J, Smith GT, Huang SC, Hoffman EJ, Ratib O, Phelps ME, et al. 13N ammonia myocardial imaging at rest and with exercise in normal volunteers: quantification of absolutemyocardial perfusionwith dynamic positron emission tomography. Circulation. 1989;80(5):1328-37. 28. Mastrocolla LE, Sousa AG, Smanio PE, Staico R, Pinto IF, Meneghelo RS, et al. Adenosine myocardial perfusion SPECT with Tc-99m-MIBI in patients with obstructive coronary artery disease: correlation between quantitative coronary angiography and intravascular ultrasound measurements. Arq Bras Cardiol. 2006;86(1):3-13. References 412